In addition, upregulation of amyloid precursor protein (APP), a protein whose aberrant processing or metabolism having been implicated in Alzheimer’s disease (AD), was observed at early stages of ALS and FTD, presumably as a compensatory response to neuronal damage or impairment of axonal transport (30). This evidence concerns the gene APP and amyotrophic lateral sclerosis.